Alexander Kristen 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Alexander Kristen
VP, Finance and Accounting
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-02-28−19,887→ 39,773 total→ Common Stock (19,887 underlying) - Exercise/Conversion
Common Stock
2025-02-28+15,926→ 74,343 total - Exercise/Conversion
Common Stock
2025-02-28+10,617→ 58,417 total - Exercise/Conversion
Common Stock
2025-02-28+19,887→ 94,230 total - Exercise/Conversion
Restricted Stock Units
2025-02-28−15,926→ 15,927 total→ Common Stock (15,926 underlying) - Tax Payment
Common Stock
2025-02-28$0.67/sh−17,862$11,968→ 76,368 total - Exercise/Conversion
Restricted Stock Units
2025-02-28−10,617→ 0 total→ Common Stock (10,617 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.